Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ACTRN12625000484448) titled 'Investigating the use of higher doses of targeted radiation and combined treatments in local control of bladder cancer care' on May 20.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety/efficacy
Primary Sponsor: South Western Sydney Local Health District
Condition:
Bladder Cancer
Bladder Cancer
Cancer - Bladder
Intervention:
Delivery of SABR dose escalation of 8-10Gy in 1 single session prior to standard course of radiotherapy with or without chemotherapy.
The SABR session is pres...